Skip to main content
Journal ArticleOPEN ACCESS

Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022

Emerging Infectious Diseases (2022) 28(6) 1276-1278
DOI: 10.3201/eid2806.220523
14Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

We studied SARS-CoV-2 genomes from travelers arriving in Hong Kong during November 2021-February 2022. In addition to Omicron and Delta variants, we detected a BA.1/BA.2 recombinant with a breakpoint near the 5′ end of the spike gene in 2 epidemiologically linked case-patients. Continued surveillance for SARS-CoV-2 recombinants is needed.

Cite

CITATION STYLE

APA

Gu, H., Ng, D. Y. M., Liu, G. Y. Z., Cheng, S. S. M., Krishnan, P., Chang, L. D. J., … Poon, L. L. M. (2022). Recombinant BA.1/BA.2 SARS-CoV-2 Virus in Arriving Travelers, Hong Kong, February 2022. Emerging Infectious Diseases, 28(6), 1276–1278. https://doi.org/10.3201/eid2806.220523

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free